CKD-1
Reduce the proportion of the U.S. population with chronic kidney disease
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 14.8 percent of the U.S. population had chronic kidney disease in 2001–06 (age adjusted to the year 2000 standard population) | ||||||
| Target: | 13.3 percent | ||||||
| Target-Setting Method: | 10 percent improvement | ||||||
| Data Sources: |
National Health and Nutrition Examination Survey (NHANES), CDC/NCHS |
||||||
| Data: |
|
||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||
| More Information: |
CKD-2
Increase the proportion of persons with chronic kidney disease (CKD) who know they have impaired renal function
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 9.4 percent of persons with CKD knew they had impaired renal function in 2001–06 (age adjusted to the year 2000 standard population) | ||||||
| Target: | 13.4 percent | ||||||
| Target-Setting Method: | 4 percentage point improvement | ||||||
| Data Sources: |
National Health and Nutrition Examination Survey (NHANES), CDC/NCHS |
||||||
| Data: |
|
||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||
| More Information: |
CKD-3
Increase the proportion of hospital patients who incurred acute kidney injury who have followup renal evaluation in 6 months post discharge
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 11.2 percent of hospital patients who incurred acute kidney injury had a followup renal evaluation in 6 months post discharge in 2007 | ||||
| Target: | 12.3 percent | ||||
| Target-Setting Method: | 10 percent improvement | ||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||
| Data: |
|
||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||
| More Information: |
CKD-4.1
Increase the proportion of persons with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and microalbuminuria
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 25.8 percent of persons with chronic kidney disease received medical evaluation with serum creatinine, lipids, and microalbuminuria in 2007 | ||||||||
| Target: | 28.4 percent | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-4.2
Increase the proportion of persons with type 1 or type 2 diabetes and chronic kidney disease who receive medical evaluation with serum creatinine, microalbuminuria, A1c, lipids, and eye examinations
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 23.0 percent of persons with type 1 or type 2 diabetes and chronic kidney disease received medical evaluation with serum creatinine, microalbuminuria, A1c, lipids, and eye examinations in 2007 | ||||||||
| Target: | 25.3 percent | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-5
Increase the proportion of persons with diabetes and chronic kidney disease who receive recommended medical treatment with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBS)
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 67.4 percent of persons with diabetes and chronic kidney disease received recommended medical treatment with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBS) in 2007 | ||||||||
| Target: | 76.3 percent | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-6.1
Reduce the proportion of persons with chronic kidney disease who have elevated blood pressure
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 22.7 percent of persons with chronic kidney disease had elevated blood pressure in 2001–06 (age adjusted to the year 2000 standard population) |
| Target: | 17.6 percent |
| Target-Setting Method: | Minimal statistical significance |
| Data Sources: |
National Health and Nutrition Examination Survey (NHANES), CDC/NCHS |
| Data: | |
| Revision History: | This objective was revised. Read more about the revision history. |
| More Information: |
CKD-6.2
Increase the proportion of adults aged 50 years and over with chronic kidney disease who currently take statins to lower their blood cholesterol
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 21.6 percent of persons aged 50 years and over with chronic kidney disease were taking statins to lower their blood cholesterol in 2001–06 (age adjusted to the year 2000 standard population) | ||||||
| Target: | 25.6 percent | ||||||
| Target-Setting Method: | Minimal statistical significance | ||||||
| Data Sources: |
National Health and Nutrition Examination Survey (NHANES), CDC/NCHS |
||||||
| Data: |
|
||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||
| More Information: |
CKD-7
Reduce the number of deaths among persons with chronic kidney disease
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 22.2 deaths per 1,000 person years occurred among persons with chronic kidney disease in 1999-2004 (age adjusted to the year 2000 standard population) | ||||||
| Target: | Not applicable | ||||||
| Target-Setting Method: | This measure is being tracked for informational purposes. If warranted, a target will be set during the decade. | ||||||
| Data Sources: |
National Death Index (NDI), CDC/NCHS; National Health and Nutrition Examination Survey (NHANES), CDC/NCHS |
||||||
| Data: |
|
||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||
| More Information: |
CKD-8
Reduce the number of new cases of end-stage renal disease (ESRD)
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 391.2 new cases of end-stage renal disease per million population were reported in 2007 (adjusted for age, sex and race) | ||||||||
| Target: | 352.0 new cases per million population | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-9.1
Reduce kidney failure due to diabetes
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 171.5 per million population reported kidney failure due to diabetes in 2007 (adjusted for age, sex and race) | ||||||||
| Target: | 154.4 per million population | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-9.2
Reduce kidney failure due to diabetes among persons with diabetes
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 2,614.2 persons with diabetes per million population reported kidney failure due to diabetes in 2007 (adjusted for age, sex and race) | ||||||||
| Target: | 2,354.4 per million population | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK; National Health Interview Survey (NHIS), CDC/NCHS |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-10
Increase the proportion of chronic kidney disease patients receiving care from a nephrologist at least 12 months before the start of renal replacement therapy
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 27.3 percent of chronic kidney disease patients received care from a nephrologist at least 12 months before the start of renal replacement therapy in 2007 | ||||||||
| Target: | 30.0 percent | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
| Baseline: | 46.0 percent of adult hemodialysis patients used arteriovenous fistulas as the primary mode of vascular access in 2006 | ||||||||
| Target: | 50.6 percent | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
Clinical Performance Measures Project (CPM), CMS; United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| More Information: |
| Baseline: | 29.0 percent of adult hemodialysis patients used catheters as the only mode of vascular access in 2006 | ||||||
| Target: | 26.1 percent | ||||||
| Target-Setting Method: | 10 percent improvement | ||||||
| Data Sources: |
Clinical Performance Measures Project (CPM), CMS; United States Renal Data System (USRDS), NIH/NIDDK |
||||||
| Data: |
|
||||||
| More Information: |
CKD-11.3
Increase the proportion of adult hemodialysis patients who use arteriovenous fistulas or have a maturing fistula as the primary mode of vascular access at the start of renal replacement therapy
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 31.6 percent of adult hemodialysis patients used arteriovenous fistulas or had a maturing fistula as the primary mode of vascular access at the start of renal replacement therapy in 2007 | ||||||||
| Target: | 34.8 percent | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
Clinical Performance Measures Project (CPM), CMS; United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-12
Increase the proportion of dialysis patients waitlisted and/or receiving a deceased donor kidney transplant within 1 year of end-stage renal disease (ESRD) start (among patients under 70 years of age)
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 16.9 percent of dialysis patients aged 70 years and under were waitlisted and/or received a deceased donor kidney transplant within 1 year of ESRD start in 2006 | ||||||||
| Target: | 18.6 percent of dialysis patients | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-13.1
Increase the proportion of patients receiving a kidney transplant within 3 years of end-stage renal disease (ESRD)
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 18.3 percent of patients aged 70 years and under received a kidney transplant within 3 years of ESRD in 2004 | ||||||||
| Target: | 20.1 percent | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
| Baseline: | 4.0 percent of patients aged 70 years and under received a preemptive transplant at the start of ESRD in 2007 | ||||||||
| Target: | Not applicable | ||||||||
| Target-Setting Method: | This measure is being tracked for informational purposes. If warranted, a target will be set during the decade. | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| More Information: |
CKD-14.1
Reduce the total number of deaths for persons on dialysis
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 208.1 deaths per 1,000 patient years at risk occurred among persons on dialysis in 2007 | ||||||
| Target: | 187.4 deaths per 1,000 patient years at risk | ||||||
| Target-Setting Method: | 10 percent improvement | ||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||
| Data: |
|
||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||
| More Information: |
CKD-14.2
Reduce the number of deaths in dialysis patients within the first 3 months of initiation of renal replacement therapy
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 372.2 deaths per 1,000 patient years at risk occurred among persons on dialysis within the first 3 months of initiation of therapy in 2007 | ||||||
| Target: | 335.0 deaths per 1,000 patient years at risk | ||||||
| Target-Setting Method: | 10 percent improvement | ||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||
| Data: |
|
||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||
| More Information: |
CKD-14.3
Reduce the number of cardiovascular deaths for persons on dialysis
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 90.3 deaths per 1,000 patient years at risk occurred from cardiovascular disease among persons on dialysis in 2007 | ||||||||
| Target: | 81.3 deaths per 1,000 patient years at risk | ||||||||
| Target-Setting Method: | 10 percent improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
CKD-14.4
Reduce the total number of deaths for persons with a functioning kidney transplant
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 30.8 deaths per 1,000 patient years at risk occurred among persons with a functioning transplant in 2007 | ||||||
| Target: | 27.8 deaths per 1,000 patient years at risk | ||||||
| Target-Setting Method: | 10 percent improvement | ||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||
| Data: |
|
||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||
| More Information: |
CKD-14.5
Reduce the number of cardiovascular deaths in persons with a functioning kidney transplant
Revised
This objective was revised. See Revision History for Details.
| Baseline: | 5.0 cardiovascular deaths per 1,000 patient years at risk occurred among persons with a functioning transplant in 2007 | ||||||||
| Target: | 3.0 cardiovascular deaths per 1,000 patient years at risk | ||||||||
| Target-Setting Method: | 2 percentage point improvement | ||||||||
| Data Sources: |
United States Renal Data System (USRDS), NIH/NIDDK |
||||||||
| Data: |
|
||||||||
| Revision History: | This objective was revised. Read more about the revision history. | ||||||||
| More Information: |
